sep 17, 1999 - Death of
Jesse Gelsinger
Description:
Jesse Gelsinger died 4 days fter being given an infusion of a corrective ornithine transcarbamoylase (OTC) gene therpay treatment after he experienced a severe immune reaction to the treatment (Sibbald 2001). His death caused the FDA to suspend the trial and create new protections for gene therapy treatment.
Added to timeline:
Date: